Patrick Mauro Investment Advisor INC. Sells 12,316 Shares of CVS Health Co. (NYSE:CVS)

Patrick Mauro Investment Advisor INC. lessened its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 9.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,698 shares of the pharmacy operator's stock after selling 12,316 shares during the quarter. CVS Health accounts for approximately 2.9% of Patrick Mauro Investment Advisor INC.'s portfolio, making the stock its 15th largest position. Patrick Mauro Investment Advisor INC.'s holdings in CVS Health were worth $5,059,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. DCM Advisors LLC boosted its holdings in shares of CVS Health by 15.5% in the 4th quarter. DCM Advisors LLC now owns 81,530 shares of the pharmacy operator's stock worth $3,435,000 after buying an additional 10,920 shares during the last quarter. Orion Capital Management LLC purchased a new position in shares of CVS Health in the 4th quarter worth about $54,000. McIlrath & Eck LLC boosted its holdings in shares of CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the last quarter. Novem Group purchased a new position in shares of CVS Health in the 4th quarter worth about $562,000. Finally, NCM Capital Management LLC boosted its holdings in shares of CVS Health by 184.2% in the 4th quarter. NCM Capital Management LLC now owns 11,225 shares of the pharmacy operator's stock worth $504,000 after buying an additional 7,276 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Price Performance

Shares of CVS stock traded up $0.58 during trading on Friday, hitting $60.80. The company had a trading volume of 8,141,495 shares, compared to its average volume of 11,329,450. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock's 50-day moving average is $66.15 and its two-hundred day moving average is $59.40. The stock has a market capitalization of $76.91 billion, a price-to-earnings ratio of 16.61, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period in the prior year, the business earned $1.31 earnings per share. CVS Health's revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, analysts predict that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.38%. The ex-dividend date was Tuesday, April 22nd. CVS Health's payout ratio is currently 63.48%.

Insider Buying and Selling at CVS Health

In other CVS Health news, SVP James David Clark sold 7,513 shares of the stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

CVS has been the topic of several recent research reports. Evercore ISI upped their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a report on Monday, January 27th. UBS Group upped their price objective on shares of CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Argus set a $77.00 price target on shares of CVS Health in a report on Tuesday, February 18th. Robert W. Baird increased their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Finally, JPMorgan Chase & Co. increased their price target on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $74.94.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.